Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Medical Cytogenetics and Molecular Genetics Laboratory, |
RCV001270236 | SCV001364367 | likely pathogenic | Premature ovarian failure | 2020-03-02 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001246139 | SCV001419479 | likely benign | Fanconi anemia | 2024-11-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001751356 | SCV001985735 | uncertain significance | not provided | 2021-03-10 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in heterozygous state in an individuals with malignant pleural mesothelioma and pancreatic cancer in published literature (Betti et al., 2017; Shindo et al., 2017); This variant is associated with the following publications: (PMID: 28687356, 28767289, 32659497) |
Genome |
RCV001824931 | SCV002074907 | not provided | Fanconi anemia complementation group A | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 07-16-2020 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
Natera, |
RCV001246139 | SCV002092511 | uncertain significance | Fanconi anemia | 2020-07-08 | no assertion criteria provided | clinical testing |